Anti-CD22 (Epratuzumab), Human IgG1 Antibody

Anti-CD22 (Epratuzumab), Human IgG1 Antibodyis available at Gentaur for Next week Delivery.

Description: Recombinant monoclonal antibody to CD22. Manufactured using Recombinant Platform with variable regions (i.e. specificity) from the hybridoma hL22 (Epratuzumab).

Immunogen Sequence:This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5–10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010).

Target Alternative Name:LymphoCide, B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14, SIGLEC2

Species Reactivities:Human, Rhesus Monkey, Cynomolgus Monkey

Tag Line:Monoclonal antibody to detect CD22 in human samples.

Formulation:In PBS only

Purification: Affinity purified using protein A

Application:/

Positive Control:/

Application And Usages:/

Handling:The antibody solution should be gently mixed before use.